Status of diabetes care: "It just doesn't get any better... or does it?"

Diabetes Care

Volumn 37, Issue 7, 2014, Pages 1782-1785

  Cefalu, William T ^a   Boulton, Andrew J M ^b   Tamborlane, William V ^c   Moses, Robert G ^d   LeRoith, Derek ^e   Greene, Eddie L ^f   Hu, Frank B ^g   Bakris, George ^h   Wylie Rosett, Judith ⁱ   Rosenstock, Julio ^j   Weinger, Katie ^k   Blonde, Lawrence ^l   De Groot, Mary ^m   Riddle, Matthew C ⁿ   Henry, Robert R ^o   Golden, Sherita Hill ^p   Rich, Stephen ^q   Reynolds, Lyn ^r  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ISLHD   (Australia)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l OCHSNER MEDICAL CENTER   (United States)

^m INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^o VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF VIRGINIA   (United States)

^r American Medical Association   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL PANCREAS; CHANGE MANAGEMENT; DECISION MAKING; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIETARY INTAKE; EDITORIAL; HUMAN; INFORMATION DISSEMINATION; INSULIN RESISTANCE; INSULIN TREATMENT; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PREGNANCY; PREVENTIVE MEDICINE; PUBLISHING; TRANSLATIONAL RESEARCH; PUBLICATION; TRENDS;

DIABETES MELLITUS; HUMANS; PERIODICALS AS TOPIC;

EID: 84903540491     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1073     Document Type: Editorial

References (41)

1. Cefalu WT. Diabetes Care to date: "the hits just keep on coming! " Diabetes Care 2013;36:1801-1803
2. Jenkins DJA, Kendall CWC, Vuksan V, et al. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care 2014;37:1806-1814
3. Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 2014;37:1789-1796
4. Østoft SH, Bagger JI, Hansen T, et al. Glucose-lowering effects and low risk of hypoglycemia in patients withmaturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial. Diabetes Care 2014;37:1797-1805
5. Rosenstock J, Jelaska A, Frappin G, et al. Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes. Diabetes Care 2014;37:1815-1823
6. Cefalu WT. Novel Communications in Diabetes: another small but significant step for Diabetes Care. Diabetes Care 2013;36:773-774
7. Cefalu WT. Diabetes Care : " State of the Union." Diabetes Care 2013;36:1-3
8. 1c reporting: " it takes two to tango " ! Diabetes Care 2012;35:2415-2416
9. Cefalu WT. "TODAY" reflects on the changing "faces " of type 2 diabetes. Diabetes Care 2013;36:1732-1734
10. Cefalu WT, Ratner RE. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: the "gift" that keeps on giving! Diabetes Care 2014;37:5 -7
11. Cefalu WT. A " spoonful of sugar" and the realities of diabetes prevention! Diabetes Care 2014;37:906-908
12. Sullivan SD, Jablonski KA, Florez JC, et al.; Diabetes Prevention Program Research Group. Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus. Diabetes Care 2014;37:909-911
13. Garvey WT, Ryan DH, Henry RR, et al. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care 2014;37:912-921
14. Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care 2014;37:922-933
15. Dunbar JA, Jayawardena A, Johnson G, et al. Scaling up diabetes prevention in Victoria, Australia: policy development, implementation, and evaluation. Diabetes Care 2014;37:934-942
16. Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949
17. Cefalu WT, Tamborlane WV. The artificial pancreas: are we there yet? Diabetes Care 2014;37:1182-1183
18. Kudva YC, Carter RE, Cobelli C, Basu R, Basu A. Closed-loop artifi cial pancreas systems: physiological input to enhance next-generation devices. Diabetes Care 2014;37:1184-1190
19. Doyle FJ III, Huyett LM, Lee JB, Zisser HC, Dassau E. Closed-loop artificial pancreas: engineering the algorithms. Diabetes Care 2014;37:1191-1197
20. Kumareswaran K, Thabit H, Leelarathna L, et al. Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study. Diabetes Care 2014;37:1198-1203
21. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014;37:1204-1211
22. Del Favero S, Bruttomesso D, Di Palma F, et al.; AP@home Consortium. First use of model predictive control in outpatientwearable artificial pancreas. Diabetes Care 2014;37:1212-1215
23. Schiavon M, Dalla Man C, Kudva YC, Basu A, Cobelli C. Quantitative estimation of insulin sensitivity in type 1 diabetic subjects wearing a sensor-augmented insulin pump. Diabetes Care 2014;37:1216-1223
24. Beck RW, Raghinaru D, Wadwa PR, et al.; In Home Closed Loop Study Group. Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care 2014;37:1224-1229
25. Gruessner RW, Gruessner AC. Pancreas transplant alone: a procedure coming of age. Diabetes Care 2013;36:2440-2447
26. Wukich DK, Armstrong DG, Attinger CE, et al. Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care 2013;36:2862-2871
27. Barnard K, Peveler RC, Holt RI. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Diabetes Care 2013;36:3337-3345
28. Vigersky RA, Fitzner K, Levinson J; Diabetes Working Group. Barriers and potential solutions to providing optimal guideline-driven care to patients with diabetes in the U.S. Diabetes Care 2013;36:3843-3849
29. Barrett HL, Dekker Nitert M, McIntyre HD, Callaway LK. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care 2014;37:1484 -1493
30. Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care 2014;37:867-875
31. Maruthur NM, Gribble MO, Bennett WL, et al. The pharmacogenetics of type 2 diabetes: a systematic review. Diabetes Care 2014;37:876-886
32. Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care 2013;36:2456-2465
33. Simó R, Sundstrom JM, Antonetti DA. Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy. Diabetes Care 2014;37:893-899
34. Cheung N, Wong IY, Wong TY. Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical effi cacy and evolving applications. Diabetes Care 2014;37:900-905
35. Home PD. Validity of meta-analysis in diabetes: we need to be aware of its limitations. Diabetes Care 2013;36:3361-3367
36. Golden SH, Bass EB. Validity of meta-analysis in diabetes:meta-analysis is an indispensable tool in evidence synthesis. Diabetes Care 2013;36:3368-3373
37. Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? Health be damned! Pour on the sugar. Diabetes Care 2014;37:950-956
38. Kahn R, Sievenpiper JL. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? We have, but the pox on sugar is overwrought and overworked. Diabetes Care 2014;37:957-962
39. Davidson M. Insulin analogs - is there a compelling reason to use them? No! Diabetes Care 2014;37:1771-1774
40. Grunberger G. Insulin analogs - are they worth it? Yes! Diabetes Care 2014;37:1767-1770
41. Kraemer FH, Ginsberg HN, Gerald M. Reaven, MD: demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease. Diabetes Care 2014;37:1178-1181